BABY News 24.26 Natus Medical Inc (BABY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Natus Medical Inc (BABY) 24.26 $BABY

Uptrend Call Working As Natus Medical Stock Rises 60.6% (BABY)
Comtex SmarTrend(R) - Fri Apr 11, 4:48PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 60.61% as of today's recent price of $23.16.

U.S. Market for Female and Neonatal Diagnostic Devices - 10 Year Forecasts for the $1 Billion Industry
M2 - Thu Apr 10, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/75j8xj/u_s_market_for) has announced the addition of the "U.S. Market for Female and Neonatal Diagnostic Devices" report to their offering. In 2012, the U.S. market for female and neonatal diagnostic devices was valued at over $1 billion. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report, despite slow national economic growth. In 2012, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the device. Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report. This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. market. Main Segments Included: - U.S. Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Genecology Ultrasound Market - Fetal and Neonatal Monitoring Market - Infant Warmer and Incubator Market Key Topics Covered: - U.S. Markets For Female And Neonatal Diagnostic Devices - Full Suite Executive Summary - Research Methodology - U.S. Female And Neonatal Diagnostic Device Market Overview - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics And Gynecology Ultrasound Market - Fetal And Neonatal Monitoring Device Market - Infant Warmer And Incubator Market - Appendix I: Gynecological Chair Market - Appendix II: Breast Tomosynthesis Companies Mentioned - C. R. Bard - CareFusion - Cooper Surgical - Devicor Medical Products - Dilon Technologies - Draeger Medical - Fujifilm Medical Systems - GE Healthcare - Hitachi-Aloka Medical Systems America - Hollister - Intact Medical - International Biomedical - Lone Oak Medical Technologies - Machnet B.V. - Natus Medical - Naviscan - Osteometer MediTech - Philips Healthcare - Philips Medical Systems - SRS Medical - Samsung Medison - Scion Medical Technologies - Siemens Healthcare - Smith & Nephew - Smiths Medical - Spacelabs Healthcare - Stryker - Sunlight Medical (Wallach Surgical) - Supersonic - Welch Allyn For more information visit http://www.researchandmarkets.com/research/75...market_for

Natus Medical to Hold 2014 First Quarter Financial Results Conference Call on April 23rd
Business Wire - Wed Apr 09, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release its 2014 first quarter financial results before the market opens on Wednesday, April 23. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.

Electrodes for Medical Devices - Global Strategic Business Report 2014
M2 - Tue Apr 08, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vg6kh7/electrodes_for) has announced the addition of the "Electrodes for Medical Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Electrodes for Medical Devices in US$ Thousand by the following Product Segments: Blood Gas Electrodes, Defibrillator Electrodes, ECG Electrodes, EEG/EMG/ENG Electrodes, Electrosurgical Electrodes, Ion-selective Electrodes, pH Electrodes, Pacemaker Electrodes, and TENS Electrodes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 111 companies including many key and niche players such as: - 3M Company - Ambu A/S - CONMED Corporation - Covidien - C.R Bard, Inc. - Katecho, Inc. - Leonhard Lang GmbH - Natus Medical Incorporated - Nikomed USA, Inc. - Philips Healthcare - Prosurg, Inc. - Rhythmlink International, LLC - Utah Medical Products Inc. - ZOLL Medical Corporation Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. OUTLOOK 2. MARKET DYNAMICS & TRENDS 3. PRODUCT OVERVIEW 4. PRODUCT INTRODUCTIONS/INNOVATIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. THE MIDDLE EAST 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 111 (including Divisions/Subsidiaries 125) - The United States (85) - Canada (4) - Japan (2) - Europe (31) - France (2) - Germany (8) - The United Kingdom (5) - Italy (2) - Spain (1) - Rest of Europe (13) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/vg...trodes_for

Uptrend Call Working As Natus Medical Stock Rises 78.4% (BABY)
Comtex SmarTrend(R) - Fri Apr 04, 11:00AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 78.43% as of today's recent price of $25.73.

Financial Results, Launches, Adjusted Conversion Rates, Upcoming Presentations, and Stock Movements - Analyst Notes on AbbVie, Chemed, Antares Pharma, Magellan Health Services, and Natus Medical
PR Newswire - Thu Apr 03, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AbbVie Inc. (NYSE: ABBV), Chemed Corp. (NYSE: CHE), Antares Pharma Inc. (NASDAQ: ATRS), Magellan Health Services Inc. (NASDAQ: MGLN), and Natus Medical Inc. (NASDAQ: BABY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Shares of BABY Up 72.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 28, 9:38AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 72.12% as of today's recent price of $24.82.

ABIOMED's Impella Trial Achieves Enrollment Target - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 2:20PM CDT
On reaching the enrollment target, ABIOMED plans to submit the compiled data and seek FDA approval for a Continuous Access Protocol.

Uptrend Call Working As Natus Medical Stock Rises 83.1% (BABY)
Comtex SmarTrend(R) - Fri Mar 21, 9:10AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 83.15% as of today's recent price of $26.41.

Veracyte (VCYT) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:21AM CDT
Veracyte, Inc. (VCYT) was a big mover last session, as the company saw its shares rise by over 8% on the day.

FDA Expands Angiovac Clearance for AngioDynamics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 10:42AM CDT
The expanded clearance for AngioVac cannula seems reasonable given the wide acceptance of the product across the U.S.

Varian Exhibits Imaging Components - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 9:14AM CDT
The exhibits put up by VAR was inclusive of the company's PaxScan wireless digital detectors, digital image processing systems as well as its full range of X-ray tubes for mammography, fluoroscopy, angiography, cardiology and cone beam CT imaging.

Meridian to Deploy Varian's TrueBeam Technology - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 3:30PM CDT
Varian's shares, which are up around 14% over a year, rose 1.4% in the trading session following the news release.

Balanced View on Intuitive Surgical - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 2:00PM CDT
Intuitive Surgical continues to see pressure on gynecology surgery, dispute related to some da Vinci procedures and changing capital spending priorities in hospitals due to the implementation of the Affordable Care Act.

LDR Holding's Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 1:39PM CDT
LDR Holding's shares reached a 52-week high following the approval of Category I code.

AngioDynamics Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 11:00AM CDT
A promising guidance, an innovative pipeline and management's efforts to leverage operational activities represent a potential upside for AngioDynamics going forward.

Natus Medical Shares Up 79.8% Since SmarTrend's Buy Recommendation (BABY)
Comtex SmarTrend(R) - Thu Mar 13, 4:39PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 5 months, Natus Medical has returned 79.82% as of today's recent price of $25.93.

Mindray Medical Sees Continued International Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 2:10PM CDT
MR delivered positive earnings surprise in each of the last four quarters

Cancer Center Uses Varian Medical's Radiosurgery System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 1:50PM CDT
VAR's Calypso "GPS for the Body" enables targeting precision for tracing tumor position in real time.

AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:18AM CDT
AngioDynamics Inc. (ANGO) was a big mover last session, as the company saw its shares rise by roughly 6% on the day.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 209

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 94

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 149

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 191

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 151

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 131

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 100

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Scatec Completes Initial Phase of Solar Power Plant Sale

Updated Category News Views 114

Scatec ASA, a heavyweight in the renewable energy arena, concluded the first phase of selling parts of its holdings in the Kalkbult, Linde, and Dreunberg solar power plants back in 2024. This deal was inked with Greenstreet 1 Proprietary Limited—a subsidiary under the STANLIB Infrastructure Fund II umbrella. Transaction Breakdown: Financials and Implications The...

Continue Reading
Taiwan Semiconductor Excels with Strong AI Demand and Profits

Updated Category News Views 227

Taiwan Semiconductor's Remarkable Performance Taiwan Semiconductor Manufacturing Co (NYSE: TSM) has recently reported outstanding financial results for the third quarter, which surpassed expectations and reflected the growing global demand for advanced microchip technologies. Investors celebrated as TSM stock saw gains following these impressive numbers, showing...

Continue Reading
China Eases Mortgage Burdens as Economy Faces Challenges

Updated Category News Views 246

The People's Bank of China (PBOC) dropped a bombshell back in mid-2024, mandating commercial banks to slash interest rates on all existing housing loans. This move was their bid to ease the financial burden on households grappling with an economy that just wouldn’t budge. You see, this wasn’t just some casual tweak; it was a strategic lifeline thrown into the...

Continue Reading
Dimethylolpropionic Acid Market Forecast: Growth Driven by Eco-Friendly Solutions

Updated Category News Views 88

Overview of the Dimethylolpropionic Acid Market The global market for dimethylolpropionic acid (DMPA) is set for substantial growth, with projections indicating an increase of USD 230.2 million from 2024 to 2028, as highlighted in recent analyses. This growth translates to a compound annual growth rate (CAGR) of 7.05%. A key factor driving this expansion is the tightening...

Continue Reading
Bowen Acquisition Corp Faces NASDAQ Delisting Risk Amid Non-Compliance

Updated Category News Views 257

Bowen Acquisition Corp's Delisting Notification from NASDAQ Bowen Acquisition Corp (NASDAQ: BOWN) has recently faced the daunting challenge of a potential delisting from the Nasdaq Global Market. The announcement came as a response to a delisting determination letter received on a notable date which has since raised concerns among investors and stakeholders alike....

Continue Reading